This mechanism may explain the low expression of A2AR with spare receptor characteristics (EC50 < KD) found in PBMC from CAD patients presenting a major cardiovascular risk 12, 13 by a release from the cells into the blood of EV carrying A2AR, constituting a circulating pool of receptors. Here, ADORA2A is linked to coronary artery disorder.